SNACS: The FAANG Of The Roaring 20s – Yahoo Finance

The roaring 20s are upon us, and the investment opportunities set in front of us are exhilarating. This new decade has a lot in store for us with tech as the driving force behind it.

FAANG was the acronym that drove the stock market to continuously new highs over the past decade: Facebook (FB), Amazon (AMZN), Apple (AAPL), Netflix (NFLX), and Google aka Alphabet (GOOGL). This is an acronym that I am sure you are familiar with. These stocks exponential returns may be exhausted, and a new set of equities are ready to take their place. It is time to look for the new FAANG.

When assessing market-shifting companies, you need to look for firms with an exciting product offering characterized by longevity and a substantial total addressable market (TAM). Firms with savvy management teams that are able to navigate through both the best and worst times nimbly.

I have chosen a new acronym of stocks that I believe could change the world in the roaring 20s. The companies include Crispr (CRSP), Sea Limited (SE), Alibaba (BABA), Nvidia (NVDA), and Splunk (SPLK) or SCANS, as I like to call it.

Here I will give a brief introduction of each stock and explain why I believe these shares will drive the market in this new decade.

Sea Limited (SE)

Sea is the leading internet company in Southeast Asia and Taiwan. These economies are digitalizing at an exponential rate, and Sea is well-positioned to take on the quickly expanding addressable market. The company operates three market leader segments, including an ecommerce platform, a digital entertainment division, and a digital payment company (Shopee, Garena, and AirPay, respectively).

The internet economy in Southeast Asia has tripled in the past 5 years to $100 billion and is expected to triple again by 2025 to $300 billion. Sea is growing at an even faster rate, with year-over-year topline appreciation in the high triple-digit percentages as the company continues to take an increasing amount of market share.

Sea Limited is going to be the tech powerhouse that helps turn the third world economies of Southeast Asia and Taiwan into digitalized world markets.

CRISPR (CRSP)

CRISPR is a biomedical firm that is on the verge of changing the world. This company can edit an individuals DNA, an achievement that is going to change modern medicine. This technology could be used to cure almost any disease if it is successfully implemented. What CRISPRs gene therapy does is splice out the bad or disease driving DNA and add healthy strands. The company is also a leader in regenerative stem-cell medicine, which could save the lives of 100s of thousands.

CRISPR has an established portfolio of life-changing therapies in its pipeline at various stages of development. Hemoglobinopathy is the closest to commercially viable and is currently in clinical trials. If it passes clinical trials, I see this stock jumping substantially.

These shares are still a risky asset considering the possibility that none of its gene-therapies make it past the clinical stage. Based on early trials, it appears that the therapy does indeed work, and this potential has begun to be priced into CRSP. The stock has appreciated 350% since it went public in late 2016, and I believe that this is just the beginning of its growth. The ability to change an individuals DNA is going to change the world of medicine.

Alibaba (BABA)

The Amazonof the East has been driving substantial growth, but I dont believe that investors are correctly valuing Alibabas fundamentals. BABA is trading at roughly 1/3rd of Amazons forward P/E valuation (seen below), despite achieving wider margins, stronger profitable, and a greater growth outlook. Alibaba is operating in one of the worlds largest and fastest-growing consumer markets (China).

Story continues

Alibaba controls not only Chinas ecommerce market but also its cloud computing space with a 47% market share. Its cloud computing space has the most room to run as Chinas cloud infrastructure continues to expand at an exponential rate high double-digit to triple-digit percentages.

Alibaba still has some geopolitical risk due to the US-China trade war, but as far as this next decades biggest equity drivers, I would replace AZMN with BABA in my portfolio.

Nvidia (NVDA)

This is the most exciting chip maker in the world today. Nvidia is known for the invention of the GPU, which is a chip original purposed for image rendering, but Nvidia has taken its capabilities far beyond this. Nvidias chips are hyper-fast and slowly becoming smarter as the technology develops. Its chips are becoming a necessity in data centers and are an essential element of AI development. I believe that one of Nvidias integrated circuits will be apart of the first true AI, which is going to change the world.

Nvidia is also leveraging 5G with its anticipated cloud gaming platform. Like cloud computing is the future of business data and analytics, cloud gaming is the future of gaming. Nvidia is making a big bet in this field with its cloud platform, GeForce NOW. This platform allows gamers to use their Macs or PCs for gaming anywhere with the high-speed, low-latency technology of Nvidias GPUs without needing Nvidias hardware locally.

Nvidia is undoubtedly a company of the future, and despite its 4-digit gains over the past decade, I believe that this stock still has legs to run. I dont think that the company has scratched the surface of what its chips could do.

Splunk (SPLK)

Splunk is a platform that helps companies utilize real-time machine data for collection, indexing, and alerts, allowing companies to uncover actionable insight from this data no matter the source or format. The company is leveraging AI and machining learning for forecasting and anticipative decision making.

Real-time data management is becoming increasingly necessary in business across industries as this digital age makes speed a competitive advantage. Splunk is well-positioned to take on the massive addressable market that is yet to recruit Splunks services. This firm is well-suited to transform the way our economy utilizes real-time data.

Take Away

The market driving stocks will undoubtedly make excellent long-term investments for the roaring 20s. SCANS will be a force to be reckoned with in this next decade. Short term volatility in these stocks shouldnt cause you to shy away from their long-term potential. I believe we may be on the edge of a market correction, so if you are worried about short-term earnings, I may wait for a pullback. If you are a long-term investor that is willing to ride this decades waves, I wouldnt hesitate to pull the trigger on these stocks.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. Theyre also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Click to get this free report Splunk Inc. (SPLK) : Free Stock Analysis Report Sea Limited Sponsored ADR (SE) : Free Stock Analysis Report NVIDIA Corporation (NVDA) : Free Stock Analysis Report Netflix, Inc. (NFLX) : Free Stock Analysis Report Alphabet Inc. (GOOGL) : Free Stock Analysis Report Facebook, Inc. (FB) : Free Stock Analysis Report CRISPR Therapeutics AG (CRSP) : Free Stock Analysis Report Alibaba Group Holding Limited (BABA) : Free Stock Analysis Report Amazon.com, Inc. (AMZN) : Free Stock Analysis Report Apple Inc. (AAPL) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research

Read the original post:
SNACS: The FAANG Of The Roaring 20s - Yahoo Finance

20 Technology Metatrends That Will Define the Next Decade – Singularity Hub

In the decade ahead, waves of exponential technological advancements are stacking atop one another, eclipsing decades of breakthroughs in scale and impact.

Emerging from these waves are 20 metatrends likely to revolutionize entire industries (old and new), redefine tomorrows generation of businesses and contemporary challenges, and transform our livelihoods from the bottom up.

Among these metatrends are augmented human longevity, the surging smart economy, AI-human collaboration, urbanized cellular agriculture, and high-bandwidth brain-computer interfaces, just to name a few.

It is here that master entrepreneurs and their teams must see beyond the immediate implications of a given technology, capturing second-order, Google-sized business opportunities on the horizon.

Welcome to a new decade of runaway technological booms, historic watershed moments, and extraordinary abundance.

Lets dive in.

(1) Continued increase in global abundance: The number of individuals in extreme poverty continues to drop, as the middle-income population continues to rise. This metatrend is driven by the convergence of high-bandwidth and low-cost communication, ubiquitous AI on the cloud, and growing access to AI-aided education and AI-driven healthcare. Everyday goods and services (finance, insurance, education, and entertainment) are being digitized and becoming fully demonetized, available to the rising billion on mobile devices.

(2) Global gigabit connectivity will connect everyone and everything, everywhere, at ultra-low cost: The deployment of both licensed and unlicensed 5G, plus the launch of a multitude of global satellite networks (OneWeb, Starlink, etc.), allow for ubiquitous, low-cost communications for everyone, everywhere, not to mention the connection of trillions of devices. And todays skyrocketing connectivity is bringing online an additional three billion individuals, driving tens of trillions of dollars into the global economy. This metatrend is driven by the convergence oflow-cost space launches, hardware advancements, 5G networks, artificial intelligence, materials science, and surging computing power.

(3) The average human healthspan will increase by 10+ years:A dozen game-changing biotech and pharmaceutical solutions (currently in Phase 1, 2, or 3 clinical trials) will reach consumers this decade, adding an additional decade to the human healthspan. Technologies include stem cell supply restoration,wnt pathway manipulation, senolytic medicines, a new generation of endo-vaccines, GDF-11, and supplementation of NMD/NAD+, among several others. And as machine learning continues to mature, AI is set to unleash countless new drug candidates, ready for clinical trials. This metatrend is driven by the convergence ofgenome sequencing, CRISPR technologies, AI, quantum computing, and cellular medicine.

(4) An age of capital abundance will see increasing access to capital everywhere: From 2016 2018 (and likely in 2019), humanity hit all-time highs in the global flow of seed capital, venture capital, and sovereign wealth fund investments. While this trend will witness some ups and downs in the wake of future recessions, it is expected to continue its overall upward trajectory. Capital abundance leads to the funding and testing of crazy entrepreneurial ideas, which in turn accelerate innovation. Already, $300 billion in crowdfunding is anticipated by 2025, democratizing capital access for entrepreneurs worldwide. This metatrend isdriven by the convergence of global connectivity, dematerialization, demonetization, and democratization.

(5) Augmented reality and the spatial webwill achieve ubiquitous deployment: The combination of augmented reality (yielding Web 3.0, or the spatial web) and 5G networks (offering 100Mb/s 10Gb/s connection speeds) will transform how we live our everyday lives, impacting every industry from retail and advertising to education and entertainment. Consumers will play, learn, and shop throughout the day in a newly intelligent, virtually overlaid world. This metatrend will be driven by the convergence ofhardware advancements, 5G networks, artificial intelligence, materials science, and surging computing power.

(6) Everything is smart, embedded with intelligence: The price of specialized machine learning chips is dropping rapidly with a rise in global demand. Combined with the explosion of low-cost microscopic sensors and the deployment of high-bandwidth networks, were heading into a decade wherein every device becomes intelligent. Your childs toy remembers her face and name. Your kids drone safely and diligently follows and videos all the children at the birthday party. Appliances respond to voice commands and anticipate your needs.

(7) AI will achieve human-level intelligence:As predicted by technologist and futurist Ray Kurzweil, artificial intelligence will reach human-level performance this decade (by 2030). Through the 2020s, AI algorithms and machine learning tools will be increasingly made open source, available on the cloud, allowing any individual with an internet connection to supplement their cognitive ability, augment their problem-solving capacity, and build new ventures at a fraction of the current cost. This metatrend will bedriven by the convergence ofglobal high-bandwidth connectivity, neural networks, and cloud computing. Every industry, spanning industrial design, healthcare, education, and entertainment, will be impacted.

(8) AI-human collaboration will skyrocket across all professions: The rise of AI as a Service (AIaaS) platforms will enable humans to partner with AI in every aspect of their work, at every level, in every industry. AIs will become entrenched in everyday business operations, serving as cognitive collaborators to employeessupporting creative tasks, generating new ideas, and tackling previously unattainable innovations. In some fields, partnership with AI will even become a requirement. For example: in the future, making certain diagnoses without the consultation of AI may be deemed malpractice.

(9) Most individuals adapt aJARVIS-like software shell to improve their quality of life: As services like Alexa, Google Home, and Apple Homepod expand in functionality, such services will eventually travel beyond the home and become your cognitive prosthetic 24/7. Imagine a secure JARVIS-like software shell that you give permission to listen to all your conversations, read your email, monitor your blood chemistry, etc. With access to such data, these AI-enabled software shells will learn your preferences, anticipate your needs and behavior, shop for you, monitor your health, and help you problem-solve in support of your mid- and long-term goals.

(10) Globally abundant, cheap renewable energy: Continued advancements in solar, wind, geothermal, hydroelectric, nuclear, and localized grids will drive humanity towards cheap, abundant, and ubiquitous renewable energy. The price per kilowatt-hour will drop below onecent per kilowatt-hour for renewables, just as storage drops below a mere three cents per kilowatt-hour, resulting in the majority displacement of fossil fuels globally. And as the worlds poorest countries are also the worlds sunniest, the democratization of both new and traditional storage technologies will grant energy abundance to those already bathed in sunlight.

(11) The insurance industry transforms from recovery after risk to prevention of risk:Today, fire insurance pays youafteryour house burns down; life insurance pays your next-of-kinafteryou die; and health insurance (which is really sick insurance) pays onlyafteryou get sick. This next decade, a new generation of insurance providers will leveragethe convergence of machine learning, ubiquitous sensors, low-cost genome sequencing, and robotics to detect risk,preventdisaster, and guarantee safety before any costs are incurred.

(12) Autonomous vehicles and flying cars will redefine human travel (soon to be far faster and cheaper):Fully autonomous vehicles, car-as-a-service fleets, and aerial ride-sharing (flying cars) will be fully operational in most major metropolitan cities in the coming decade. The cost of transportation will plummet 3-4X, transforming real estate, finance, insurance, the materials economy, and urban planning. Where you live and work, and how you spend your time, will all be fundamentally reshaped by this future of human travel. Your kids and elderly parents will never drive. This metatrend will bedriven by the convergence ofmachine learning, sensors, materials science, battery storage improvements, and ubiquitous gigabit connections.

(13) On-demand production and on-demand delivery will birth an instant economy of things:Urban dwellers will learn to expect instant fulfillment of their retail orders as drone and robotic last-mile delivery services carry products from local supply depots directly to your doorstep. Further riding the deployment of regional on-demand digital manufacturing (3D printing farms), individualized products can be obtained within hours, anywhere, anytime. This metatrend isdriven by the convergence of networks, 3D printing, robotics, and artificial intelligence.

(14) Ability to sense and know anything, anytime, anywhere:Were rapidly approaching the era wherein 100 billion sensors (the Internet of Everything) is monitoring and sensing (imaging, listening, measuring) every facet of our environments, all the time. Global imaging satellites, drones, autonomous car LIDARs, and forward-looking augmented reality (AR) headset cameras are all part of a global sensor matrix, together allowing us to know anything, anytime, anywhere. This metatrend isdriven by the convergence ofterrestrial, atmospheric and space-based sensors, vast data networks, and machine learning. In this future, its not what you know, but rather the quality of the questions you ask that will be most important.

(15) Disruption of advertising:As AI becomes increasingly embedded in everyday life, your custom AI will soon understand what you want better than you do. In turn, we will begin to both trust and rely upon our AIs to make most of our buying decisions, turning over shopping to AI-enabled personal assistants. Your AI might make purchases based upon your past desires, current shortages, conversations youve allowed your AI to listen to, or by tracking where your pupils focus on a virtual interface (i.e. what catches your attention). As a result, the advertising industrywhich normally competes foryourattention (whether at the Superbowl or through search engines)will have a hard time influencing your AI. This metatrend isdriven by the convergence ofmachine learning, sensors, augmented reality, and 5G/networks.

(16) Cellular agriculture moves from the lab into inner cities, providing high-quality protein that is cheaper and healthier: This next decade will witness the birth of the most ethical, nutritious, and environmentally sustainable protein production system devised by humankind. Stem cell-based cellular agriculture will allow the production of beef, chicken, and fishanywhere, on-demand, with far higher nutritional content, and a vastly lower environmental footprint than traditional livestock options. This metatrend isenabled by the convergence ofbiotechnology, materials science, machine learning, and AgTech.

(17) High-bandwidth brain-computer interfaces (BCIs) will come online for public use: Technologist and futurist Ray Kurzweil has predicted that in the mid-2030s, we will begin connecting the human neocortex to the cloud. This next decade will see tremendous progress in that direction, first serving those with spinal cord injuries, whereby patients will regain both sensory capacity and motor control. Yet beyond assisting those with motor function loss, several BCI pioneers are now attempting to supplement their baseline cognitive abilities, a pursuit with the potential to increase their sensorium, memory, and even intelligence. This metatrend is fueled by the convergence ofmaterials science, machine learning, and robotics.

(18) High-resolution VRwill transform both retail and real estate shopping:High-resolution, lightweight virtual reality headsets will allow individuals at home to shop for everything from clothing to real estate from the convenience of their living room. Need a new outfit? Your AI knows your detailed body measurements and can whip up a fashion show featuring your avatar wearing the latest 20 designs on a runway. Want to see how your furniture might look inside a house youre viewing online? No problem! Your AI can populate the property with your virtualized inventory and give you a guided tour. This metatrend isenabled by the convergence of: VR, machine learning, and high-bandwidth networks.

(19) Increased focus on sustainability and the environment:An increase in global environmental awareness and concern over global warming will drive companies to invest in sustainability, both from a necessity standpoint and for marketing purposes. Breakthroughs in materials science, enabled by AI, will allow companies to drive tremendous reductions in waste and environmental contamination. One companys waste will become another companys profit center. This metatrend isenabled by the convergence ofmaterials science, artificial intelligence, and broadband networks.

(20) CRISPR and gene therapies will minimize disease:A vast range of infectious diseases, ranging from AIDS to Ebola, are now curable. In addition, gene-editing technologies continue to advance in precision and ease of use, allowing families to treat and ultimatelycurehundreds of inheritable genetic diseases. This metatrend isdriven by the convergence of various biotechnologies (CRISPR, gene therapy), genome sequencing, and artificial intelligence.

(1) A360 Executive Mastermind:If youre an exponentially and abundance-minded entrepreneur who would like coaching directly from me, consider joining my Abundance 360 Mastermind, a highly selective community of 360 CEOs and entrepreneurs who I coach for 3 days every January in Beverly Hills, Ca. Through A360, I provide my members with context and clarity about how converging exponential technologies will transform every industry. Im committed to running A360 for the course of an ongoing 25-year journey as a countdown to the Singularity.

If youd like to learn more and consider joining our 2020 membership,apply here.

(2) Abundance-Digital Online Community:Ive also created a Digital/Online community of bold, abundance-minded entrepreneurs called Abundance-Digital. Abundance-Digital is Singularity Universitys onramp for exponential entrepreneurs those who want to get involved and play at a higher level.Click here to learn more.

(Both A360 and Abundance-Digital are part of Singularity Universityyour participation opens you to a global community.)

This article originally appeared ondiamandis.com. Read theoriginal article here.

Image Credit: Image by Free-Photos from Pixabay

Here is the original post:
20 Technology Metatrends That Will Define the Next Decade - Singularity Hub

LANL Scientists And International Partners Create 3-D Image Of Heart RNA Structure For First Time – My Blog – Los Alamos Daily Post

The first 3-D images have been created of an RNA molecule known as Braveheart for its role in transforming stem cells into heart cells. Courtesy/LANL

LANL News:

Scientists at Los Alamos National Laboratory and international partners have created the first 3-D images of a special type of RNA molecule that is critical for stem cell programming and known as the dark matter of the genome.

As far as we know, said corresponding author Karissa Sanbonmatsu, this is the first full 3-D structural study of any long, non-coding RNA (lncRNA) other than a partial structure.

Sanbonmatsu is a structural biologist at LANL.

A better understanding of these RNAs could lead to new strategies in regenerative medicine for people with heart conditions due to cardiovascular disease or aging,Sanbonmatsu said.

The team used a technique called small angle X-ray scattering (SAXS) that reveals the 3-D envelope of the RNA molecule, according to Trushar Patel, a Canadian professor on the team. Next, with the help of machine learning and high-performance computing, they made atomistic models to fit inside the envelopes this included the creation of an atomistic model that is also the longest of an isolated RNA (636 nucleotides) to date, said Doo Nam Kim, lead author on the Nature Communications paper.

Our work represents the first step in showing that these difficult-to-image RNAs do possess 3-D structures, and that these molecular structures may very well determine how they operate, Sanbonmatsu said. The RNA studied is called Braveheart it triggers the transformation of stem cells into heart cells.

Before the human genome was sequenced in 2000, it was thought that it mostly contained instructions for proteins, the workhorse molecules of human cells. Scientists were shocked to discover that less than 10 percent of the genome encoded proteins. Ever since, the other 90 percent was deemed to be junk DNA or dark matter. Enter RNA, the molecular cousin of DNA. Scientists originally assumed the main purpose of RNA was simply to coordinate as a messenger for DNA in the synthesis of proteins. However, it has recently been shown that more than 90 percent of the genome encodes a new and mysterous class of RNAs, called long non-coding RNA molecules (lncRNA).

These RNA molecules help to control the turning on and off of genes; their malfunction causes birth defects, autism and even cancer in some cases. They also are key to reprogramming adult stem cells. Even though the molecules make up 90 percent of the genome, scientists have almost no idea how they work, or even what they look like. In this study, one of the largest RNA-only 3-D studies, the new 3-D images sets the stagefor future studies that will shed more light on how they control genes.

Publication:

Zinc-finger protein CNBP alters the 3-D structure of lncRNA Braveheart in solution Authors: Karissa Y. Sanbonmatsu, Doo Nam Kim and Scott P. Hennelly of Los Alamos National Laboratory and New Mexico Consortium; Bernhard C. Thiel and Ivo L. Hofacker of University of Vienna, Austria; Tyler Mrozowich and Trushar R. Patel of University of Lethbridge, Canada. Nature Communications, DOI 10.1038/s41467-019-13942-4

Funding:

National Institutes of Health, Los Alamos Institutional Computing and Los Alamos Laboratory Directed R& D, and Diamond Light Source (UK).

AboutLos Alamos National Laboratory:

Los Alamos National Laboratory, a multidisciplinary research institution engaged in strategic science on behalf of national security, is operated by Triad, a public service oriented, national security science organization equally owned by its three founding members: Battelle Memorial Institute (Battelle), the Texas A&M University System (TAMUS), and the Regents of the University of California (UC) for the Department of Energys National Nuclear Security Administration.

Los Alamos enhances national security by ensuring the safety and reliability of the U.S. nuclear stockpile, developing technologies to reduce threats from weapons of mass destruction, and solving problems related to energy, environment, infrastructure, health, and global security concerns.

Go here to read the rest:
LANL Scientists And International Partners Create 3-D Image Of Heart RNA Structure For First Time - My Blog - Los Alamos Daily Post

BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week – Yahoo Finance

NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that Chaim Lebovits, President and Chief Executive Officer, will provide a corporate overview at the 2020 Biotech Showcase, being held on January 13-15, 2020 at the Hilton San Francisco Union Square in San Francisco, California.

Mr. Lebovits will also present at the 3rd Annual Neuroscience Innovation Forum, taking place on January 12, 2020, at the Marines Memorial Club in San Francisco. Additionally, Ralph Kern M.D., MHSc, BrainStorms Chief Operating Officer and Chief Medical Officer, will participate on aRare & Orphan Diseases Panel.

Meetings

BrainStorms senior management will also be hosting institutional investor and partnering meetings at the 2020 Biotech Showcase conference (https://goo.gl/SGFm62). Please use the Investor contact information provided below to schedule a meeting.

About NurOwn

NurOwn (autologous MSC-NTF cells) represent a promising investigational approach to targeting disease pathways important in neurodegenerative disorders. MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo. MSCs are converted into MSC-NTF cells by growing them under patented conditions that induce the cells to secrete high levels of neurotrophic factors. Autologous MSC-NTF cells can effectively deliver multiple NTFs and immunomodulatory cytokines directly to the site of damage to elicit a desired biological effect and ultimately slow or stabilize disease progression. NurOwn is currently being evaluated in a Phase 3 ALS randomized placebo-controlled trial and in a Phase 2 open-label multicenter trial in Progressive MS.

About BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The Company holds the rights to clinical development and commercialization of the NurOwn technology platform used to produce autologous MSC-NTF cells through an exclusive, worldwide licensing agreement. Autologous MSC-NTF cells have received Orphan Drug status designation from the U.S. Food and Drug Administration (U.S. FDA) and the European Medicines Agency (EMA) in ALS. BrainStorm has fully enrolled a Phase 3 pivotal trial in ALS (NCT03280056), investigating repeat-administration of autologous MSC-NTF cells at six sites in the U.S., supported by a grant from the California Institute for Regenerative Medicine (CIRM CLIN2-0989). The pivotal study is intended to support a filing for U.S. FDA approval of autologous MSC-NTF cells in ALS. For more information, visit BrainStorm's website at http://www.brainstorm-cell.com.

Safe-Harbor Statement

Statements in this announcement other than historical data and information, including statements regarding future clinical trial enrollment and data, constitute "forward-looking statements" and involve risks and uncertainties that could causeBrainStorm Cell Therapeutics Inc.'sactual results to differ materially from those stated or implied by such forward-looking statements. Terms and phrases such as "may", "should", "would", "could", "will", "expect", "likely", "believe", "plan", "estimate", "predict", "potential", and similar terms and phrases are intended to identify these forward-looking statements. The potential risks and uncertainties include, without limitation, BrainStorms need to raise additional capital, BrainStorms ability to continue as a going concern, regulatory approval of BrainStorms NurOwn treatment candidate, the success of BrainStorms product development programs and research, regulatory and personnel issues, development of a global market for our services, the ability to secure and maintain research institutions to conduct our clinical trials, the ability to generate significant revenue, the ability of BrainStorms NurOwn treatment candidate to achieve broad acceptance as a treatment option for ALS or other neurodegenerative diseases, BrainStorms ability to manufacture and commercialize the NurOwn treatment candidate, obtaining patents that provide meaningful protection, competition and market developments, BrainStorms ability to protect our intellectual property from infringement by third parties, heath reform legislation, demand for our services, currency exchange rates and product liability claims and litigation,; and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q available athttp://www.sec.gov. These factors should be considered carefully, and readers should not place undue reliance on BrainStorm's forward-looking statements. The forward-looking statements contained in this press release are based on the beliefs, expectations and opinions of management as of the date of this press release. We do not assume any obligation to update forward-looking statements to reflect actual results or assumptions if circumstances or management's beliefs, expectations or opinions should change, unless otherwise required by law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

Story continues

Excerpt from:
BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week - Yahoo Finance

Mesenchymal Stem Cells Market to Perceive Substantial Growth During 2019 to 2027 | Lonza, Thermo Fisher, Bio-Techne, Miltenyi Biotec, PromoCell GmbH,…

The increasing use of mesenchymal stem cells (MSCs) for the treatment of diseases and disabilities of the growing aging population is having a positive influence on the global mesenchymal stem cells market. Mesenchymal stem cells are adult stem cells that are of various types such as adipocytes, osteocytes, monocytes, and chondrocytes. The main function of mesenchymal stem cells is to replace or repair damaged tissue.

Mesenchymal stem cells are multipotent, i.e. they can produce more than one type of specialized cell. These specialized cells have their own distinguishing shapes, structures, and functions, with each of them belonging to a particular tissue.

Request Global Mesenchymal Stem Cells Market Research Study Sample

The Global Mesenchymal Stem Cells Market Report profoundly studies past and present phase of the global Mesenchymal Stem Cells market to provide valuable and reliable forecast estimation that drives Mesenchymal Stem Cells market player to obtain comprehensive market scenario for near future. It facilitates Mesenchymal Stem Cells manufacturers and company officials with analysis based on upcoming investment opportunities, challenges, risks, and threats and prompts them to precisely plan their future activities.

Top Leading Vendors :-

Lonza, Thermo Fisher, Bio-Techne, Miltenyi Biotec, PromoCell GmbH, Irvine Scientific, Axol Bioscience, STEMCELL Technologies, Biological Industries, R&D Systems, Inc., Cell Applications, Inc., Cyagen Biosciences Inc., Cytori Therapeutics Inc., BrainStorm Cell Therapeutics, Stemedica Cell Technologies, Inc., and Celprogen, Inc.

The report further explains the performance of the Mesenchymal Stem Cells market from the last five years. According to the research the market is expected to dominate international market structure with commendable revenue outcome and it would be one of the most influential markets in the world with heavily escalating annual growth rate.

Ask For Discount on Global Visualization Software Market Study

On the basis of product type, the global Mesenchymal Stem Cells Market is segmented into:

On the basis of application, the global Mesenchymal Stem Cells Market is segmented into:

The report divides the global Mesenchymal Stem Cells market into several significant segments such as Mesenchymal Stem Cells types, applications, technology, end-users, and region. It offers complete and comprehensive cognition for each segment alongside an evaluation of their consumption, sales volume, and revenue outcomes. The proposed segmentation analysis also aids a player to form a customer-oriented approach, make business strategies, and set targets and goals for the firm.

Enquiry before Buying of Global Visualization Software Market

Besides, the report renders such insights that help to determine upcoming business opportunities, challenges, risks, threats, and obstacles; and enables to make informed decisions. It also depicts provincial trade policies, entry barriers, environmental and financial concerns, and other factors that could potentially obstruct Mesenchymal Stem Cells market growth in the future.

Kindly contact us in case of queries or customized data need to be added. sales@reportconsultant.com

Go here to read the rest:
Mesenchymal Stem Cells Market to Perceive Substantial Growth During 2019 to 2027 | Lonza, Thermo Fisher, Bio-Techne, Miltenyi Biotec, PromoCell GmbH,...

Understanding the developmental conditions of the human spine – Tech Explorist

Almost two decades ago, Biologist Olivier Pourqui established the segmental organization of the vertebral column in embryogenesis, when pairs of somites are rhythmically produced by the presomitic mesoderm (PSM). The tempo of somite formation is controlled by a molecular oscillator known as the segmentation clock. Although this oscillator has been well-characterized in model organisms, whether a similar oscillator exists in humans remains unknown.

Along with his colleagues, Olivier now has created the first lab-dish models of the segmentation clock that use stem cells derived from adult human tissue. The team, through this study, confirm that the segmentation clock exists in human also. Moreover, this offers the scientific community the first in vitro system enabling the study of very early spine development in humans.

Pourqui, professor of genetics in the Blavatnik Institute at Harvard Medical School, said, We know virtually nothing about human development of somites, which form between the third and fourth week after fertilization before most people know theyre pregnant. Our system should be a powerful one to study the underlying regulation of the segmentation clock.

Margarete Diaz-Cuadros, a graduate student in the Pourqui lab, said, Our innovative experimental system now allows us to compare mouse and human development side by side. I am excited to unravel what makes human development unique.

The study, in other words, opens up the new pathway towards understanding developmental conditions of the spine, such as congenital scoliosis, as well as diseases involving tissues that arise from the same region of the embryo, known as the paraxial mesoderm.

Scientists became surprised when they found that the segmentation clock began ticking in both the mouse and human cell dishes and that the cells didnt first need to be arranged on a 3D scaffold more closely resembling the body.

The segmentation clock ticks every five hours in the human cells and every 2.5 hours in the mouse cells. The difference in frequency parallels the difference in gestation time between mice and humans.

This work was funded by the National Institutes of Health grant 5R01HD085121 and is published in the Jan. 8 issues of Nature.

See the original post here:
Understanding the developmental conditions of the human spine - Tech Explorist

The Checkout: Powering Plant and Cell-based Innovations – NOSH

The Checkout: Powering Plant and Cell-based Innovations

Welcome to The Checkout: an express lane for weekly news you need to know, always 10 items or less.

New protein sources are becoming increasingly important for reasons including sustainability, animal welfare, and personal wellness. And as younger consumers seek flexitarian diets, and are more open-minded about technologys role in food innovation, both the plant-based and cell-based meat landscapes are growing and diversifying.

Krogers Simple Truth Launches Plant Based Burgers and Grounds

Retailer Kroger this week announced the launch of new refrigerated plant-based meat alternatives under a new private label brand Simple Truth Emerge, part of the retailers natural and organic Simple Truth Plant-Based line. The new patties and grounds will join the line of meatless sausages and deli slices, oat milk and plant-based chocolate chip cookie dough and sour cream.

The Simple Truth brand overall has 1,550 products and generated $2.3 billion in sales last year, Joe Grieshaber, Krogers senior VP of merchandising, noted in a release. Kroger plans to add more meat and dairy alternatives to the portfolio, launching 50 new Simple Truth Plant-Based products in 2020.

Kroger anticipates interest in plant-based products to continue to grow in 2020, with the category being one of the key drivers of our natural and organic sales, Grieshaber said.

The new patties and grounds, each with 20 grams of pea-based protein per serving, will be sold in the retailers meat case. To further understand shopper preferences and behaviors, Kroger last month also launched a 16-week plant-based product placement test within the meat sections of 60 stores.

Tofurky Rethinks Burgers

Forty year-old plant-based brand Tofurky this week launched a new plant-based burger patty with an enhanced sustainability angle that it says more closely resembles the texture of meat. The brand previously sold veggie burgers in retail, but discontinued that line at the start of 2019.

We are very happy with the final recipe and beef-style texture, Jaime Athos, Tofurky president and CEO, said in a release. Many flexitarians resolve to go completely plant-based for the month of January, so we wanted to provide a new burger option now, ahead of summer grilling, that is affordable, delicious, and accessible.

The burgers contain soy protein, vegetable protein and wheat gluten and are lightly seasoned with salt, onion and garlic. According to a Tofurky spokesperson, the burgers soy base is more sustainable than other burgers pea bases and offers twice the protein. Further, the burgers shelf life is four times longer than other plant-based burgers helping fight food waste.

The products packaging, which includes two individually-sealed patties, is also designed from recyclable materials in a smaller pack size than other offerings in order to reduce waste.

New Age Meats Raises $2.7M

Cultivated meat company New Age Meats yesterday announced the close of a $2.7 million round of seed funding led by venture firm ff Venture Capital, with additional investors including Agronomics Ltd, Sand Hill Angels, Supernode Ventures, Hemisphere Ventures, and Kairos Ventures. SOSV also took part, following on their pre-seed investment into the company as part of science accelerator IndieBio.

Founded in 2018, the Berkeley-based company seeks to develop technology to make meat from animal-cells using automation and data science in stem cell research and bioreactor optimization. With the new funding, New Age Meats plans to expand its science and engineering teams and develop new products.

This funding enables us to grow our team, invest in automation equipment, and iterate our unique cultivators we design in house. We cant wait to share tasty, sustainable cultivated meat with avid meat eaters, founder and CEO Brian Spears said in a release.

Impossible Sausage Hits Burger King Breakfast

Impossible Foods will expand beyond its plant-based, beef-style Impossible Burger, this week announcing an Impossible Sausage patty, made from a new ground Impossible Pork product, at the Consumer Electronics Show (CES) in Las Vegas.

The sausage will roll out in fast food retailer Burger King, where the brand also offers an Impossible Whopper that debuted nationwide last summer. Burger King will test an Impossible Sausage Croissanwich featuring the patty in 139 Burger King locations later this month.

Meanwhile, the company did not announce distribution plans for Impossible Pork to-date, aside from that it plans to release the product into foodservice before pursuing retail distribution.

The new products mark the companys first move past its plant-based burger, which debuted in 2016 in restaurants and launched in retail this past September.

Impossible Foods CEO Pat Brown told CES attendees that the company is ramping up R&D efforts and planning to double its R&D team in the next year.

Not only is the pace of new product development getting faster, but were getting better at getting better, Brown said on CNBCs Squawk on the Street on Tuesday. The whole innovation cycle is accelerating.

Visit link:
The Checkout: Powering Plant and Cell-based Innovations - NOSH

Cultured Meat Startup New Age Meats Secures $2.7M in Seed Round – vegconomist – the vegan business magazine

New Age Meats

Berkeley-based cultured meat company, New Age Meats, announced yesterday the closing of $2.7 million in seed round funding, led by New Yorks ff Venture Capital,with participation from Agronomics Ltd, Sand Hill Angels, Supernode Ventures, Hemisphere Ventures, and Kairos Ventures.

New Age Meats was founded in 2018 and is a graduate of IndieBios accelerator program. The company aims to develop technology to make meat from animal cells instead of animal slaughter by using automation and data science in stem cell research and bioreactor optimization.

Brian Spears, CEO and founder, said: This funding enables us to grow our team, invest in automation equipment, and iterate our unique cultivators we design in house. We cant wait to share tasty, sustainable cultivated meat with avid meat eaters.

AJ Plotkin, Partner at ff Venture Capital, said: As a firm we focus on transformative technologies and visionary founders. Weve found that in Brian and the team at New Age Meats. We are confident cultivated meat will be part of the food economy long term.

Related

More:
Cultured Meat Startup New Age Meats Secures $2.7M in Seed Round - vegconomist - the vegan business magazine

Stem Cell Gun Devices Market Projected to Witness Vigorous Expansion by 2019 2027 – Food & Beverage Herald

TMRs latest report on global Stem Cell Gun Devices market

The recent market intelligence study by Transparency Market Research elaborates the all in all perspective of the worldwide Stem Cell Gun Devices market, from its historical growth through the future outlook. The report is scrutinized on the basis of product type, end use, region and market players. Each segment depicted based on market share, revenue, and demand prospect.

Analysts at TMR find that the global Stem Cell Gun Devices market reached a value of ~US$ xx Mn/Bn in 2018 and is anticipated to grow at CAGR of xx% during the forecast period 2019-2029. The growth is primarily driven by increasing demand for Stem Cell Gun Devices among the consumers, better disposable income, and enhanced GDP in developing countries.

Buy reports at discounted prices!!! Offer valid till midnight!!!

Request For Discount On This Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=D&rep_id=71718

Market distribution:

Market Segmentation By Application

Based on application, the global stem cell gun devices market can be divided into:

Global Stem Cell Gun Devices Market Segmentation By End-user

In terms of end-user, the global stem cell gun devices market can be classified into:

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

The regional analysis covers:

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request Sample Report @ https://www.transparencymarketresearch.co/sample/sample.php?flag=B&rep_id=71718

After reading the Stem Cell Gun Devices market report, readers can:

What kind of questions the Stem Cell Gun Devices market report answers?

RequestTOC For ThisReport @ https://www.transparencymarketresearch.co/sample/sample.php?flag=T&rep_id=71718

Why go for Transparency Market Research

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companys exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRs experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market ResearchState Tower90 State Street,Suite 700,Albany, NY 12207United StatesTel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Email:[emailprotected]Website:http://www.transparencymarketresearch.com

This post was originally published on Food and Beverage Herald

View original post here:
Stem Cell Gun Devices Market Projected to Witness Vigorous Expansion by 2019 2027 - Food & Beverage Herald

Stem Cell Manufacturing Market Size, Top Companies, Business Opportunities and Growth 2020 to 2027 – Pro News Time

New Jersey, United States, The recent report added by Verified Market Research gives a detailed account of the drivers and restraints in the Stem Cell Manufacturing Market. The research report, titled [Stem Cell Manufacturing Market Research Report 2020] presents a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Stem Cell Manufacturing market and the current trends that are likely to shape its future. Primary and secondary research methodologies have been used to put together an exhaustive report on the subject. Analysts have offered unbiased outlook on the global Stem Cell Manufacturing market to guide clients toward a well-informed business decision.

Stem Cell Manufacturing Market was valued at USD 9.53 Billion in 2018 and is projected to reach USD 14.52 Billion by 2026, growing at a CAGR of 5.4% from 2019 to 2026.

Request a Sample Copy of this report @https://www.verifiedmarketresearch.com/download-sample/?rid=28592&utm_source=PNT&utm_medium=002

Top 10 Companies in the Global Stem Cell Manufacturing Market Research Report:

Global Stem Cell Manufacturing Market: Competitive Landscape

Competitive landscape of a market explains strategies incorporated by key players of the market. Key developments and shift in management in the recent years by players has been explained through company profiling. This helps readers to understand the trends that will accelerate the growth of market. It also includes investment strategies, marketing strategies, and product development plans adopted by major players of the market. The market forecast will help readers make better investments.

Global Stem Cell Manufacturing Market: Drivers and Restrains

This section of the report discusses various drivers and restrains that have shaped the global market. The detailed study of numerous drivers of the market enable readers to get a clear perspective of the market, which includes market environment, government policies, product innovations, breakthroughs, and market risks.

The research report also points out the myriad opportunities, challenges, and market barriers present in the Global Stem Cell Manufacturing Market. The comprehensive nature of the information will help the reader determine and plan strategies to benefit from. Restrains, challenges, and market barriers also help the reader to understand how the company can prevent itself from facing downfall.

Global Stem Cell Manufacturing Market: Segment Analysis

This section of the report includes segmentation such as application, product type, and end user. These segmentations aid in determining parts of market that will progress more than others. The segmentation analysis provides information about the key elements that are thriving the specific segments better than others. It helps readers to understand strategies to make sound investments. The Global Stem Cell Manufacturing Market is segmented on the basis of product type, applications, and its end users.

Global Stem Cell Manufacturing Market: Regional Analysis

This part of the report includes detailed information of the market in different regions. Each region offers different scope to the market as each region has different government policy and other factors. The regions included in the report are North America, South America, Europe, Asia Pacific, and the Middle East. Information about different region helps the reader to understand global market better.

Ask for Discount @https://www.verifiedmarketresearch.com/ask-for-discount/?rid=28592&utm_source=PNT&utm_medium=002

Table of Content

1 Introduction of Stem Cell Manufacturing Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Stem Cell Manufacturing Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Stem Cell Manufacturing Market, By Deployment Model

5.1 Overview

6 Stem Cell Manufacturing Market, By Solution

6.1 Overview

7 Stem Cell Manufacturing Market, By Vertical

7.1 Overview

8 Stem Cell Manufacturing Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Stem Cell Manufacturing Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Request Customization of Report @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Manufacturing-Market/?utm_source=PNT&utm_medium=002

Highlights of Report

About Us:

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne Fernandes Call: +1 (650) 781 4080 Email: [emailprotected]

Visit link:
Stem Cell Manufacturing Market Size, Top Companies, Business Opportunities and Growth 2020 to 2027 - Pro News Time